News

Filter

Current filters:

AmgenAnti-virals

More cancer and HIV drugs added to Australian PBS

07-12-2011

More than 160,000 patients will benefit directly from changes to Australia’s Pharmaceutical Benefits…

AmgenAnti-viralsAsia-PacificGilead SciencesOncologyPharmaceuticalPrezistaPricingRegulationXgeva

Regulatory updates for Incivek, Xgeva and Corlux in North America

23-08-2011

In a batch of regulatory news released yesterday, Vertex Pharmaceuticals (Nasdaq: VRTX) said that Health…

AmgenAnti-viralsCorcept TherapeuticsCorluxIncivekNorth AmericaPharmaceuticalRare diseasesRegulationVertexXgeva

Amgen and Xencor ink $500 million option pact to co-develop novel antibody for autoimmune diseases

07-01-2011

US biotech major Amgen (Nasdaq: AMGN) and privately-held Xencor have signed a collaboration to develop…

AmgenAnti-viralsBiotechnologyLicensingPharmaceuticalXencor

COMPANY SPOTLIGHT

Menarini

Back to top